In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...
Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs. Read more.
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A new study found that adding pulmonary vein isolation to cavo-tricuspid isthmus ablation in ...